PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH.

Rachael M MoloneyPenny MohrEmma HaweKoonal ShahMartina GarauAdrian Towse

Published in: International journal of technology assessment in health care (2016)

Industry perceptions that CER/RE will change payers' evidentiary requirements in the future are consistent with our findings. Growing investment in payers' own data and increased reliance on policy tools to control diffusion of new drugs may also influence the type of evidence industry will be required to produce by 2020.

Keyphrases

current status
healthcare
public health
randomized controlled trial
systematic review
electronic health record
mental health
big data
machine learning
artificial intelligence
deep learning
data analysis